血浆置换联合利妥昔单抗治疗特发性血栓性血小板减少性紫癜6例疗效观察

周琛; 李东; 张凡; 李翠萍; 环亚红; 宋艳智; 夏素琴; 廖海英; 隋雪梅; 卢应连

doi:10.13201/j.issn.1004-2806.2014.01.017

血浆置换联合利妥昔单抗治疗特发性血栓性血小板减少性紫癜6例疗效观察

- 南京明基医院血液科(南京, 210019)

详细信息

通讯作者: 李东,E-mail:lidongjs@hotmail.com

中图分类号: R554.6

收稿日期: 2013-05-06

Efficacy of plasmapheresis combined rituximab treatment on idiopathic thrombotic thrombocytopenic purpura

More Information

Corresponding author: LI Dong, E-mail: lidongjs@hotmail.com

Received Date: 06 May 2013

摘要

- 特发性血栓性血小板减少性紫癜 /
- 血浆置换 /
- 利妥昔单抗
- idiopathic thrombotic thrombocytopenic purpura /
- plasmapheresis /
- rituximab

HTML全文

参考文献(13)

[1]	WESTWOOD J P,WEBSTER H,MCGUCKIN S,et al.Rituximab for thrombotic thrombocytopenic purpure:benefit of early administration during acute episodes and use of prophylaxis to prevent relapse[J].J Thromb Haemost,2013,11:481-490.
[2]	中华医学会血液学分会血栓与止血学组.血栓性血小板减少性紫癜诊断与治疗中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):983-984.
[3]	TUN N M,VILLANI G M.Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura:a systematic review with pooled data analysis[J].J Thromb Thrombolysis,2012,34:347-359.
[4]	SCULLY M,HUNT B J,BENJAMIN S,et al.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies[J].Br J Haematol,2012,158:323-335.
[5]	高维强,苏健,邢秀萍,等.von Willebrand因子裂解酶活性水平的检测及其临床应用[J].中国实验血液学杂志,2004,12(6):726-729.
[6]	隋涛,杨仁池.利妥昔单抗在治疗血栓性血小板减少性紫癜中的应用[J].中华血液学杂志,2011,32(7):487-488.
[7]	KREMER HOVINGA J A,MEYER S C.Current management of thrombotic thrombocytopenic purpura[J].Curr Opin Hematol,2008,15:445-450.
[8]	SCULLY M.Rituximab in the treatment of TTP[J].Hematology,2012(Suppl 1):S22-S24.
[9]	GEORGE J N,WOODSON R D,KISS J E,et al.Rituximab therapy for thrombotic thrombocytopenic purpura:a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders[J].J Clin Apher,2006,21:49-56.
[10]	LING H T,FIELD J J,BLINDER M A,et al.Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura:a report of 13 cases and review of the literature[J].Am J Hematol,2009,84:418-421.
[11]	JASTI S,COYLE T,GENTILE T,et al.Rituximab as an adjunct to plasma exchange in TTP:a report of 12 cases and review of literature[J].J Clin Apher,2008,23:151-156.
[12]	SCULLY M,MCDONALD V,CAVENAGH J,et al.A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocy-topenic purpura[J].Blood,2011,118:1746-1753.
[13]	IIOKA F,SHIMOMURA D,ISHII T,et al.Short-and Long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura:four case reports[J].Int J Hematol,2012,96:506-512.